Eli Lilly stock pre-market at EUR 1031.30: plus 0.16 percent
Published on 10/07/2026 at 08:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Eli Lilly stock was at EUR 1031.30 pre-market at 8:16 a.m. CEST on October 7, 2026, according to Lang & Schwarz. That was a gain of plus 0.16 percent versus the Lang & Schwarz prior close of EUR 1029.70 on October 6, 2026.
Pre-market trading
The Lang & Schwarz bid was EUR 1029.40 and the ask was EUR 1033.20. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Eli Lilly stock.
Lilly schedules dermatology data
Eli Lilly and Company said on October 5, 2026, that it will present 21 poster presentations across its dermatology portfolio at the Fall Clinical Dermatology Conference in Las Vegas from October 8 through October 11.
The presentations include data on EBGLYSS, or lebrikizumab-lbkz, in moderate-to-severe atopic dermatitis; analyses of concomitant Taltz and Zepbound use in psoriasis and obesity or overweight; and long-term outcomes for Olumiant in pediatric patients with severe alopecia areata, according to the company release.
